Global OTC Medicine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global OTC Medicine market size was valued at US$ 25220 million in 2023. With growing demand in downstream market, the OTC Medicine is forecast to a readjusted size of US$ 35680 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global OTC Medicine market. OTC Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of OTC Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the OTC Medicine market.
OTC medicines are also called over-the-counter drugs, as opposed to prescription drugs, which refer to drugs that can be purchased from pharmacies without a doctor's prescription. These drugs have been used for a long time in clinical practice, with definite efficacy and fewer adverse drug reactions. Patients do not need to have too much professional knowledge, and they can use them safely with only the drug instructions and labels.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on OTC Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the OTC Medicine market. It may include historical data, market segmentation by Type (e.g., Gastrointestinal Tract, Dermatology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the OTC Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the OTC Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the OTC Medicine industry. This include advancements in OTC Medicine technology, OTC Medicine new entrants, OTC Medicine new investment, and other innovations that are shaping the future of OTC Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the OTC Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for OTC Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the OTC Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting OTC Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the OTC Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the OTC Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the OTC Medicine market.
Market Segmentation:
OTC Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global OTC Medicine market?
What factors are driving OTC Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Medicine market opportunities vary by end market size?
How does OTC Medicine break out type, application?
According to our LPI (LP Information) latest study, the global OTC Medicine market size was valued at US$ 25220 million in 2023. With growing demand in downstream market, the OTC Medicine is forecast to a readjusted size of US$ 35680 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global OTC Medicine market. OTC Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of OTC Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the OTC Medicine market.
OTC medicines are also called over-the-counter drugs, as opposed to prescription drugs, which refer to drugs that can be purchased from pharmacies without a doctor's prescription. These drugs have been used for a long time in clinical practice, with definite efficacy and fewer adverse drug reactions. Patients do not need to have too much professional knowledge, and they can use them safely with only the drug instructions and labels.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on OTC Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the OTC Medicine market. It may include historical data, market segmentation by Type (e.g., Gastrointestinal Tract, Dermatology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the OTC Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the OTC Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the OTC Medicine industry. This include advancements in OTC Medicine technology, OTC Medicine new entrants, OTC Medicine new investment, and other innovations that are shaping the future of OTC Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the OTC Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for OTC Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the OTC Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting OTC Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the OTC Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the OTC Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the OTC Medicine market.
Market Segmentation:
OTC Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Gastrointestinal Tract
- Dermatology
- Otolaryngology
- Nutrition/Vitamins
- Others
- Pharmacy
- Hospital Pharmacy
- Online Retailer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Procter & Gamble
- Johnson & Johnson
- GlaxoSmithKline Plc
- Abbott Laboratories
- Amway Corporation
- Bayer
- Aktienge
- Sanofi
- Pfizer
- Reckitt Benckiser Group
- Church & Dwight
- Bayer HealthCare
- AstraZeneca
- BioGaia
- Bristol Myers Squibb
- Chr. Hansen
- Cipla
- CoLucid
- Daiichi Sankyo
- Friggs
- DSM
- Eisai
- Eli Lilly
- Herbalife
- Euradite
What is the 10-year outlook for the global OTC Medicine market?
What factors are driving OTC Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Medicine market opportunities vary by end market size?
How does OTC Medicine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global OTC Medicine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for OTC Medicine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for OTC Medicine by Country/Region, 2019, 2023 & 2030
2.2 OTC Medicine Segment by Type
2.2.1 Gastrointestinal Tract
2.2.2 Dermatology
2.2.3 Otolaryngology
2.2.4 Nutrition/Vitamins
2.2.5 Others
2.3 OTC Medicine Sales by Type
2.3.1 Global OTC Medicine Sales Market Share by Type (2019-2024)
2.3.2 Global OTC Medicine Revenue and Market Share by Type (2019-2024)
2.3.3 Global OTC Medicine Sale Price by Type (2019-2024)
2.4 OTC Medicine Segment by Application
2.4.1 Pharmacy
2.4.2 Hospital Pharmacy
2.4.3 Online Retailer
2.4.4 Others
2.5 OTC Medicine Sales by Application
2.5.1 Global OTC Medicine Sale Market Share by Application (2019-2024)
2.5.2 Global OTC Medicine Revenue and Market Share by Application (2019-2024)
2.5.3 Global OTC Medicine Sale Price by Application (2019-2024)
3 GLOBAL OTC MEDICINE BY COMPANY
3.1 Global OTC Medicine Breakdown Data by Company
3.1.1 Global OTC Medicine Annual Sales by Company (2019-2024)
3.1.2 Global OTC Medicine Sales Market Share by Company (2019-2024)
3.2 Global OTC Medicine Annual Revenue by Company (2019-2024)
3.2.1 Global OTC Medicine Revenue by Company (2019-2024)
3.2.2 Global OTC Medicine Revenue Market Share by Company (2019-2024)
3.3 Global OTC Medicine Sale Price by Company
3.4 Key Manufacturers OTC Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Medicine Product Location Distribution
3.4.2 Players OTC Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OTC MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic OTC Medicine Market Size by Geographic Region (2019-2024)
4.1.1 Global OTC Medicine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global OTC Medicine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic OTC Medicine Market Size by Country/Region (2019-2024)
4.2.1 Global OTC Medicine Annual Sales by Country/Region (2019-2024)
4.2.2 Global OTC Medicine Annual Revenue by Country/Region (2019-2024)
4.3 Americas OTC Medicine Sales Growth
4.4 APAC OTC Medicine Sales Growth
4.5 Europe OTC Medicine Sales Growth
4.6 Middle East & Africa OTC Medicine Sales Growth
5 AMERICAS
5.1 Americas OTC Medicine Sales by Country
5.1.1 Americas OTC Medicine Sales by Country (2019-2024)
5.1.2 Americas OTC Medicine Revenue by Country (2019-2024)
5.2 Americas OTC Medicine Sales by Type
5.3 Americas OTC Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Medicine Sales by Region
6.1.1 APAC OTC Medicine Sales by Region (2019-2024)
6.1.2 APAC OTC Medicine Revenue by Region (2019-2024)
6.2 APAC OTC Medicine Sales by Type
6.3 APAC OTC Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe OTC Medicine by Country
7.1.1 Europe OTC Medicine Sales by Country (2019-2024)
7.1.2 Europe OTC Medicine Revenue by Country (2019-2024)
7.2 Europe OTC Medicine Sales by Type
7.3 Europe OTC Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa OTC Medicine by Country
8.1.1 Middle East & Africa OTC Medicine Sales by Country (2019-2024)
8.1.2 Middle East & Africa OTC Medicine Revenue by Country (2019-2024)
8.2 Middle East & Africa OTC Medicine Sales by Type
8.3 Middle East & Africa OTC Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Medicine
10.3 Manufacturing Process Analysis of OTC Medicine
10.4 Industry Chain Structure of OTC Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Medicine Distributors
11.3 OTC Medicine Customer
12 WORLD FORECAST REVIEW FOR OTC MEDICINE BY GEOGRAPHIC REGION
12.1 Global OTC Medicine Market Size Forecast by Region
12.1.1 Global OTC Medicine Forecast by Region (2025-2030)
12.1.2 Global OTC Medicine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Medicine Forecast by Type
12.7 Global OTC Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Procter & Gamble
13.1.1 Procter & Gamble Company Information
13.1.2 Procter & Gamble OTC Medicine Product Portfolios and Specifications
13.1.3 Procter & Gamble OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Procter & Gamble Main Business Overview
13.1.5 Procter & Gamble Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson OTC Medicine Product Portfolios and Specifications
13.2.3 Johnson & Johnson OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 GlaxoSmithKline Plc
13.3.1 GlaxoSmithKline Plc Company Information
13.3.2 GlaxoSmithKline Plc OTC Medicine Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Plc OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Plc Main Business Overview
13.3.5 GlaxoSmithKline Plc Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories OTC Medicine Product Portfolios and Specifications
13.4.3 Abbott Laboratories OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Amway Corporation
13.5.1 Amway Corporation Company Information
13.5.2 Amway Corporation OTC Medicine Product Portfolios and Specifications
13.5.3 Amway Corporation OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amway Corporation Main Business Overview
13.5.5 Amway Corporation Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer OTC Medicine Product Portfolios and Specifications
13.6.3 Bayer OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Aktienge
13.7.1 Aktienge Company Information
13.7.2 Aktienge OTC Medicine Product Portfolios and Specifications
13.7.3 Aktienge OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Aktienge Main Business Overview
13.7.5 Aktienge Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi OTC Medicine Product Portfolios and Specifications
13.8.3 Sanofi OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer OTC Medicine Product Portfolios and Specifications
13.9.3 Pfizer OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Reckitt Benckiser Group
13.10.1 Reckitt Benckiser Group Company Information
13.10.2 Reckitt Benckiser Group OTC Medicine Product Portfolios and Specifications
13.10.3 Reckitt Benckiser Group OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Reckitt Benckiser Group Main Business Overview
13.10.5 Reckitt Benckiser Group Latest Developments
13.11 Church & Dwight
13.11.1 Church & Dwight Company Information
13.11.2 Church & Dwight OTC Medicine Product Portfolios and Specifications
13.11.3 Church & Dwight OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Church & Dwight Main Business Overview
13.11.5 Church & Dwight Latest Developments
13.12 Bayer HealthCare
13.12.1 Bayer HealthCare Company Information
13.12.2 Bayer HealthCare OTC Medicine Product Portfolios and Specifications
13.12.3 Bayer HealthCare OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bayer HealthCare Main Business Overview
13.12.5 Bayer HealthCare Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca OTC Medicine Product Portfolios and Specifications
13.13.3 AstraZeneca OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 BioGaia
13.14.1 BioGaia Company Information
13.14.2 BioGaia OTC Medicine Product Portfolios and Specifications
13.14.3 BioGaia OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioGaia Main Business Overview
13.14.5 BioGaia Latest Developments
13.15 Bristol Myers Squibb
13.15.1 Bristol Myers Squibb Company Information
13.15.2 Bristol Myers Squibb OTC Medicine Product Portfolios and Specifications
13.15.3 Bristol Myers Squibb OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Bristol Myers Squibb Main Business Overview
13.15.5 Bristol Myers Squibb Latest Developments
13.16 Chr. Hansen
13.16.1 Chr. Hansen Company Information
13.16.2 Chr. Hansen OTC Medicine Product Portfolios and Specifications
13.16.3 Chr. Hansen OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Chr. Hansen Main Business Overview
13.16.5 Chr. Hansen Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla OTC Medicine Product Portfolios and Specifications
13.17.3 Cipla OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 CoLucid
13.18.1 CoLucid Company Information
13.18.2 CoLucid OTC Medicine Product Portfolios and Specifications
13.18.3 CoLucid OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 CoLucid Main Business Overview
13.18.5 CoLucid Latest Developments
13.19 Daiichi Sankyo
13.19.1 Daiichi Sankyo Company Information
13.19.2 Daiichi Sankyo OTC Medicine Product Portfolios and Specifications
13.19.3 Daiichi Sankyo OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Daiichi Sankyo Main Business Overview
13.19.5 Daiichi Sankyo Latest Developments
13.20 Friggs
13.20.1 Friggs Company Information
13.20.2 Friggs OTC Medicine Product Portfolios and Specifications
13.20.3 Friggs OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Friggs Main Business Overview
13.20.5 Friggs Latest Developments
13.21 DSM
13.21.1 DSM Company Information
13.21.2 DSM OTC Medicine Product Portfolios and Specifications
13.21.3 DSM OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 DSM Main Business Overview
13.21.5 DSM Latest Developments
13.22 Eisai
13.22.1 Eisai Company Information
13.22.2 Eisai OTC Medicine Product Portfolios and Specifications
13.22.3 Eisai OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Eisai Main Business Overview
13.22.5 Eisai Latest Developments
13.23 Eli Lilly
13.23.1 Eli Lilly Company Information
13.23.2 Eli Lilly OTC Medicine Product Portfolios and Specifications
13.23.3 Eli Lilly OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Eli Lilly Main Business Overview
13.23.5 Eli Lilly Latest Developments
13.24 Herbalife
13.24.1 Herbalife Company Information
13.24.2 Herbalife OTC Medicine Product Portfolios and Specifications
13.24.3 Herbalife OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Herbalife Main Business Overview
13.24.5 Herbalife Latest Developments
13.25 Euradite
13.25.1 Euradite Company Information
13.25.2 Euradite OTC Medicine Product Portfolios and Specifications
13.25.3 Euradite OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Euradite Main Business Overview
13.25.5 Euradite Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global OTC Medicine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for OTC Medicine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for OTC Medicine by Country/Region, 2019, 2023 & 2030
2.2 OTC Medicine Segment by Type
2.2.1 Gastrointestinal Tract
2.2.2 Dermatology
2.2.3 Otolaryngology
2.2.4 Nutrition/Vitamins
2.2.5 Others
2.3 OTC Medicine Sales by Type
2.3.1 Global OTC Medicine Sales Market Share by Type (2019-2024)
2.3.2 Global OTC Medicine Revenue and Market Share by Type (2019-2024)
2.3.3 Global OTC Medicine Sale Price by Type (2019-2024)
2.4 OTC Medicine Segment by Application
2.4.1 Pharmacy
2.4.2 Hospital Pharmacy
2.4.3 Online Retailer
2.4.4 Others
2.5 OTC Medicine Sales by Application
2.5.1 Global OTC Medicine Sale Market Share by Application (2019-2024)
2.5.2 Global OTC Medicine Revenue and Market Share by Application (2019-2024)
2.5.3 Global OTC Medicine Sale Price by Application (2019-2024)
3 GLOBAL OTC MEDICINE BY COMPANY
3.1 Global OTC Medicine Breakdown Data by Company
3.1.1 Global OTC Medicine Annual Sales by Company (2019-2024)
3.1.2 Global OTC Medicine Sales Market Share by Company (2019-2024)
3.2 Global OTC Medicine Annual Revenue by Company (2019-2024)
3.2.1 Global OTC Medicine Revenue by Company (2019-2024)
3.2.2 Global OTC Medicine Revenue Market Share by Company (2019-2024)
3.3 Global OTC Medicine Sale Price by Company
3.4 Key Manufacturers OTC Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Medicine Product Location Distribution
3.4.2 Players OTC Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OTC MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic OTC Medicine Market Size by Geographic Region (2019-2024)
4.1.1 Global OTC Medicine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global OTC Medicine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic OTC Medicine Market Size by Country/Region (2019-2024)
4.2.1 Global OTC Medicine Annual Sales by Country/Region (2019-2024)
4.2.2 Global OTC Medicine Annual Revenue by Country/Region (2019-2024)
4.3 Americas OTC Medicine Sales Growth
4.4 APAC OTC Medicine Sales Growth
4.5 Europe OTC Medicine Sales Growth
4.6 Middle East & Africa OTC Medicine Sales Growth
5 AMERICAS
5.1 Americas OTC Medicine Sales by Country
5.1.1 Americas OTC Medicine Sales by Country (2019-2024)
5.1.2 Americas OTC Medicine Revenue by Country (2019-2024)
5.2 Americas OTC Medicine Sales by Type
5.3 Americas OTC Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Medicine Sales by Region
6.1.1 APAC OTC Medicine Sales by Region (2019-2024)
6.1.2 APAC OTC Medicine Revenue by Region (2019-2024)
6.2 APAC OTC Medicine Sales by Type
6.3 APAC OTC Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe OTC Medicine by Country
7.1.1 Europe OTC Medicine Sales by Country (2019-2024)
7.1.2 Europe OTC Medicine Revenue by Country (2019-2024)
7.2 Europe OTC Medicine Sales by Type
7.3 Europe OTC Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa OTC Medicine by Country
8.1.1 Middle East & Africa OTC Medicine Sales by Country (2019-2024)
8.1.2 Middle East & Africa OTC Medicine Revenue by Country (2019-2024)
8.2 Middle East & Africa OTC Medicine Sales by Type
8.3 Middle East & Africa OTC Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Medicine
10.3 Manufacturing Process Analysis of OTC Medicine
10.4 Industry Chain Structure of OTC Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Medicine Distributors
11.3 OTC Medicine Customer
12 WORLD FORECAST REVIEW FOR OTC MEDICINE BY GEOGRAPHIC REGION
12.1 Global OTC Medicine Market Size Forecast by Region
12.1.1 Global OTC Medicine Forecast by Region (2025-2030)
12.1.2 Global OTC Medicine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Medicine Forecast by Type
12.7 Global OTC Medicine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Procter & Gamble
13.1.1 Procter & Gamble Company Information
13.1.2 Procter & Gamble OTC Medicine Product Portfolios and Specifications
13.1.3 Procter & Gamble OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Procter & Gamble Main Business Overview
13.1.5 Procter & Gamble Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson OTC Medicine Product Portfolios and Specifications
13.2.3 Johnson & Johnson OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 GlaxoSmithKline Plc
13.3.1 GlaxoSmithKline Plc Company Information
13.3.2 GlaxoSmithKline Plc OTC Medicine Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Plc OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GlaxoSmithKline Plc Main Business Overview
13.3.5 GlaxoSmithKline Plc Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories OTC Medicine Product Portfolios and Specifications
13.4.3 Abbott Laboratories OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Amway Corporation
13.5.1 Amway Corporation Company Information
13.5.2 Amway Corporation OTC Medicine Product Portfolios and Specifications
13.5.3 Amway Corporation OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Amway Corporation Main Business Overview
13.5.5 Amway Corporation Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer OTC Medicine Product Portfolios and Specifications
13.6.3 Bayer OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Aktienge
13.7.1 Aktienge Company Information
13.7.2 Aktienge OTC Medicine Product Portfolios and Specifications
13.7.3 Aktienge OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Aktienge Main Business Overview
13.7.5 Aktienge Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi OTC Medicine Product Portfolios and Specifications
13.8.3 Sanofi OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer OTC Medicine Product Portfolios and Specifications
13.9.3 Pfizer OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Reckitt Benckiser Group
13.10.1 Reckitt Benckiser Group Company Information
13.10.2 Reckitt Benckiser Group OTC Medicine Product Portfolios and Specifications
13.10.3 Reckitt Benckiser Group OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Reckitt Benckiser Group Main Business Overview
13.10.5 Reckitt Benckiser Group Latest Developments
13.11 Church & Dwight
13.11.1 Church & Dwight Company Information
13.11.2 Church & Dwight OTC Medicine Product Portfolios and Specifications
13.11.3 Church & Dwight OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Church & Dwight Main Business Overview
13.11.5 Church & Dwight Latest Developments
13.12 Bayer HealthCare
13.12.1 Bayer HealthCare Company Information
13.12.2 Bayer HealthCare OTC Medicine Product Portfolios and Specifications
13.12.3 Bayer HealthCare OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bayer HealthCare Main Business Overview
13.12.5 Bayer HealthCare Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca OTC Medicine Product Portfolios and Specifications
13.13.3 AstraZeneca OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 BioGaia
13.14.1 BioGaia Company Information
13.14.2 BioGaia OTC Medicine Product Portfolios and Specifications
13.14.3 BioGaia OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioGaia Main Business Overview
13.14.5 BioGaia Latest Developments
13.15 Bristol Myers Squibb
13.15.1 Bristol Myers Squibb Company Information
13.15.2 Bristol Myers Squibb OTC Medicine Product Portfolios and Specifications
13.15.3 Bristol Myers Squibb OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Bristol Myers Squibb Main Business Overview
13.15.5 Bristol Myers Squibb Latest Developments
13.16 Chr. Hansen
13.16.1 Chr. Hansen Company Information
13.16.2 Chr. Hansen OTC Medicine Product Portfolios and Specifications
13.16.3 Chr. Hansen OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Chr. Hansen Main Business Overview
13.16.5 Chr. Hansen Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla OTC Medicine Product Portfolios and Specifications
13.17.3 Cipla OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 CoLucid
13.18.1 CoLucid Company Information
13.18.2 CoLucid OTC Medicine Product Portfolios and Specifications
13.18.3 CoLucid OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 CoLucid Main Business Overview
13.18.5 CoLucid Latest Developments
13.19 Daiichi Sankyo
13.19.1 Daiichi Sankyo Company Information
13.19.2 Daiichi Sankyo OTC Medicine Product Portfolios and Specifications
13.19.3 Daiichi Sankyo OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Daiichi Sankyo Main Business Overview
13.19.5 Daiichi Sankyo Latest Developments
13.20 Friggs
13.20.1 Friggs Company Information
13.20.2 Friggs OTC Medicine Product Portfolios and Specifications
13.20.3 Friggs OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Friggs Main Business Overview
13.20.5 Friggs Latest Developments
13.21 DSM
13.21.1 DSM Company Information
13.21.2 DSM OTC Medicine Product Portfolios and Specifications
13.21.3 DSM OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 DSM Main Business Overview
13.21.5 DSM Latest Developments
13.22 Eisai
13.22.1 Eisai Company Information
13.22.2 Eisai OTC Medicine Product Portfolios and Specifications
13.22.3 Eisai OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Eisai Main Business Overview
13.22.5 Eisai Latest Developments
13.23 Eli Lilly
13.23.1 Eli Lilly Company Information
13.23.2 Eli Lilly OTC Medicine Product Portfolios and Specifications
13.23.3 Eli Lilly OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Eli Lilly Main Business Overview
13.23.5 Eli Lilly Latest Developments
13.24 Herbalife
13.24.1 Herbalife Company Information
13.24.2 Herbalife OTC Medicine Product Portfolios and Specifications
13.24.3 Herbalife OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Herbalife Main Business Overview
13.24.5 Herbalife Latest Developments
13.25 Euradite
13.25.1 Euradite Company Information
13.25.2 Euradite OTC Medicine Product Portfolios and Specifications
13.25.3 Euradite OTC Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Euradite Main Business Overview
13.25.5 Euradite Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. OTC Medicine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. OTC Medicine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gastrointestinal Tract
Table 4. Major Players of Dermatology
Table 5. Major Players of Otolaryngology
Table 6. Major Players of Nutrition/Vitamins
Table 7. Major Players of Others
Table 8. Global OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 9. Global OTC Medicine Sales Market Share by Type (2019-2024)
Table 10. Global OTC Medicine Revenue by Type (2019-2024) & ($ million)
Table 11. Global OTC Medicine Revenue Market Share by Type (2019-2024)
Table 12. Global OTC Medicine Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 14. Global OTC Medicine Sales Market Share by Application (2019-2024)
Table 15. Global OTC Medicine Revenue by Application (2019-2024)
Table 16. Global OTC Medicine Revenue Market Share by Application (2019-2024)
Table 17. Global OTC Medicine Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global OTC Medicine Sales by Company (2019-2024) & (K Units)
Table 19. Global OTC Medicine Sales Market Share by Company (2019-2024)
Table 20. Global OTC Medicine Revenue by Company (2019-2024) ($ Millions)
Table 21. Global OTC Medicine Revenue Market Share by Company (2019-2024)
Table 22. Global OTC Medicine Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers OTC Medicine Producing Area Distribution and Sales Area
Table 24. Players OTC Medicine Products Offered
Table 25. OTC Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global OTC Medicine Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global OTC Medicine Sales Market Share Geographic Region (2019-2024)
Table 30. Global OTC Medicine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global OTC Medicine Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global OTC Medicine Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global OTC Medicine Sales Market Share by Country/Region (2019-2024)
Table 34. Global OTC Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global OTC Medicine Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 37. Americas OTC Medicine Sales Market Share by Country (2019-2024)
Table 38. Americas OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas OTC Medicine Revenue Market Share by Country (2019-2024)
Table 40. Americas OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 41. Americas OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 42. APAC OTC Medicine Sales by Region (2019-2024) & (K Units)
Table 43. APAC OTC Medicine Sales Market Share by Region (2019-2024)
Table 44. APAC OTC Medicine Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC OTC Medicine Revenue Market Share by Region (2019-2024)
Table 46. APAC OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 47. APAC OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 48. Europe OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 49. Europe OTC Medicine Sales Market Share by Country (2019-2024)
Table 50. Europe OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe OTC Medicine Revenue Market Share by Country (2019-2024)
Table 52. Europe OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 53. Europe OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa OTC Medicine Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa OTC Medicine Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of OTC Medicine
Table 61. Key Market Challenges & Risks of OTC Medicine
Table 62. Key Industry Trends of OTC Medicine
Table 63. OTC Medicine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. OTC Medicine Distributors List
Table 66. OTC Medicine Customer List
Table 67. Global OTC Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global OTC Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC OTC Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC OTC Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global OTC Medicine Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global OTC Medicine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global OTC Medicine Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global OTC Medicine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Procter & Gamble Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 82. Procter & Gamble OTC Medicine Product Portfolios and Specifications
Table 83. Procter & Gamble OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Procter & Gamble Main Business
Table 85. Procter & Gamble Latest Developments
Table 86. Johnson & Johnson Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson OTC Medicine Product Portfolios and Specifications
Table 88. Johnson & Johnson OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. GlaxoSmithKline Plc Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline Plc OTC Medicine Product Portfolios and Specifications
Table 93. GlaxoSmithKline Plc OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. GlaxoSmithKline Plc Main Business
Table 95. GlaxoSmithKline Plc Latest Developments
Table 96. Abbott Laboratories Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 97. Abbott Laboratories OTC Medicine Product Portfolios and Specifications
Table 98. Abbott Laboratories OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Abbott Laboratories Main Business
Table 100. Abbott Laboratories Latest Developments
Table 101. Amway Corporation Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 102. Amway Corporation OTC Medicine Product Portfolios and Specifications
Table 103. Amway Corporation OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Amway Corporation Main Business
Table 105. Amway Corporation Latest Developments
Table 106. Bayer Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 107. Bayer OTC Medicine Product Portfolios and Specifications
Table 108. Bayer OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Bayer Main Business
Table 110. Bayer Latest Developments
Table 111. Aktienge Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 112. Aktienge OTC Medicine Product Portfolios and Specifications
Table 113. Aktienge OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Aktienge Main Business
Table 115. Aktienge Latest Developments
Table 116. Sanofi Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi OTC Medicine Product Portfolios and Specifications
Table 118. Sanofi OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. Pfizer Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer OTC Medicine Product Portfolios and Specifications
Table 123. Pfizer OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Pfizer Main Business
Table 125. Pfizer Latest Developments
Table 126. Reckitt Benckiser Group Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 127. Reckitt Benckiser Group OTC Medicine Product Portfolios and Specifications
Table 128. Reckitt Benckiser Group OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Reckitt Benckiser Group Main Business
Table 130. Reckitt Benckiser Group Latest Developments
Table 131. Church & Dwight Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 132. Church & Dwight OTC Medicine Product Portfolios and Specifications
Table 133. Church & Dwight OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. Church & Dwight Main Business
Table 135. Church & Dwight Latest Developments
Table 136. Bayer HealthCare Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 137. Bayer HealthCare OTC Medicine Product Portfolios and Specifications
Table 138. Bayer HealthCare OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Bayer HealthCare Main Business
Table 140. Bayer HealthCare Latest Developments
Table 141. AstraZeneca Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 142. AstraZeneca OTC Medicine Product Portfolios and Specifications
Table 143. AstraZeneca OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. AstraZeneca Main Business
Table 145. AstraZeneca Latest Developments
Table 146. BioGaia Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 147. BioGaia OTC Medicine Product Portfolios and Specifications
Table 148. BioGaia OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. BioGaia Main Business
Table 150. BioGaia Latest Developments
Table 151. Bristol Myers Squibb Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 152. Bristol Myers Squibb OTC Medicine Product Portfolios and Specifications
Table 153. Bristol Myers Squibb OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Bristol Myers Squibb Main Business
Table 155. Bristol Myers Squibb Latest Developments
Table 156. Chr. Hansen Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 157. Chr. Hansen OTC Medicine Product Portfolios and Specifications
Table 158. Chr. Hansen OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Chr. Hansen Main Business
Table 160. Chr. Hansen Latest Developments
Table 161. Cipla Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 162. Cipla OTC Medicine Product Portfolios and Specifications
Table 163. Cipla OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Cipla Main Business
Table 165. Cipla Latest Developments
Table 166. CoLucid Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 167. CoLucid OTC Medicine Product Portfolios and Specifications
Table 168. CoLucid OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. CoLucid Main Business
Table 170. CoLucid Latest Developments
Table 171. Daiichi Sankyo Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 172. Daiichi Sankyo OTC Medicine Product Portfolios and Specifications
Table 173. Daiichi Sankyo OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Daiichi Sankyo Main Business
Table 175. Daiichi Sankyo Latest Developments
Table 176. Friggs Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 177. Friggs OTC Medicine Product Portfolios and Specifications
Table 178. Friggs OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Friggs Main Business
Table 180. Friggs Latest Developments
Table 181. DSM Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 182. DSM OTC Medicine Product Portfolios and Specifications
Table 183. DSM OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. DSM Main Business
Table 185. DSM Latest Developments
Table 186. Eisai Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 187. Eisai OTC Medicine Product Portfolios and Specifications
Table 188. Eisai OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Eisai Main Business
Table 190. Eisai Latest Developments
Table 191. Eli Lilly Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 192. Eli Lilly OTC Medicine Product Portfolios and Specifications
Table 193. Eli Lilly OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. Eli Lilly Main Business
Table 195. Eli Lilly Latest Developments
Table 196. Herbalife Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 197. Herbalife OTC Medicine Product Portfolios and Specifications
Table 198. Herbalife OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Herbalife Main Business
Table 200. Herbalife Latest Developments
Table 201. Euradite Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 202. Euradite OTC Medicine Product Portfolios and Specifications
Table 203. Euradite OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Euradite Main Business
Table 205. Euradite Latest Developments
.
Table 1. OTC Medicine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. OTC Medicine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gastrointestinal Tract
Table 4. Major Players of Dermatology
Table 5. Major Players of Otolaryngology
Table 6. Major Players of Nutrition/Vitamins
Table 7. Major Players of Others
Table 8. Global OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 9. Global OTC Medicine Sales Market Share by Type (2019-2024)
Table 10. Global OTC Medicine Revenue by Type (2019-2024) & ($ million)
Table 11. Global OTC Medicine Revenue Market Share by Type (2019-2024)
Table 12. Global OTC Medicine Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 14. Global OTC Medicine Sales Market Share by Application (2019-2024)
Table 15. Global OTC Medicine Revenue by Application (2019-2024)
Table 16. Global OTC Medicine Revenue Market Share by Application (2019-2024)
Table 17. Global OTC Medicine Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global OTC Medicine Sales by Company (2019-2024) & (K Units)
Table 19. Global OTC Medicine Sales Market Share by Company (2019-2024)
Table 20. Global OTC Medicine Revenue by Company (2019-2024) ($ Millions)
Table 21. Global OTC Medicine Revenue Market Share by Company (2019-2024)
Table 22. Global OTC Medicine Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers OTC Medicine Producing Area Distribution and Sales Area
Table 24. Players OTC Medicine Products Offered
Table 25. OTC Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global OTC Medicine Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global OTC Medicine Sales Market Share Geographic Region (2019-2024)
Table 30. Global OTC Medicine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global OTC Medicine Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global OTC Medicine Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global OTC Medicine Sales Market Share by Country/Region (2019-2024)
Table 34. Global OTC Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global OTC Medicine Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 37. Americas OTC Medicine Sales Market Share by Country (2019-2024)
Table 38. Americas OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas OTC Medicine Revenue Market Share by Country (2019-2024)
Table 40. Americas OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 41. Americas OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 42. APAC OTC Medicine Sales by Region (2019-2024) & (K Units)
Table 43. APAC OTC Medicine Sales Market Share by Region (2019-2024)
Table 44. APAC OTC Medicine Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC OTC Medicine Revenue Market Share by Region (2019-2024)
Table 46. APAC OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 47. APAC OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 48. Europe OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 49. Europe OTC Medicine Sales Market Share by Country (2019-2024)
Table 50. Europe OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe OTC Medicine Revenue Market Share by Country (2019-2024)
Table 52. Europe OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 53. Europe OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa OTC Medicine Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa OTC Medicine Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa OTC Medicine Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa OTC Medicine Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa OTC Medicine Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa OTC Medicine Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of OTC Medicine
Table 61. Key Market Challenges & Risks of OTC Medicine
Table 62. Key Industry Trends of OTC Medicine
Table 63. OTC Medicine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. OTC Medicine Distributors List
Table 66. OTC Medicine Customer List
Table 67. Global OTC Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global OTC Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC OTC Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC OTC Medicine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa OTC Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa OTC Medicine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global OTC Medicine Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global OTC Medicine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global OTC Medicine Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global OTC Medicine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Procter & Gamble Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 82. Procter & Gamble OTC Medicine Product Portfolios and Specifications
Table 83. Procter & Gamble OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Procter & Gamble Main Business
Table 85. Procter & Gamble Latest Developments
Table 86. Johnson & Johnson Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson OTC Medicine Product Portfolios and Specifications
Table 88. Johnson & Johnson OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. GlaxoSmithKline Plc Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline Plc OTC Medicine Product Portfolios and Specifications
Table 93. GlaxoSmithKline Plc OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. GlaxoSmithKline Plc Main Business
Table 95. GlaxoSmithKline Plc Latest Developments
Table 96. Abbott Laboratories Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 97. Abbott Laboratories OTC Medicine Product Portfolios and Specifications
Table 98. Abbott Laboratories OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Abbott Laboratories Main Business
Table 100. Abbott Laboratories Latest Developments
Table 101. Amway Corporation Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 102. Amway Corporation OTC Medicine Product Portfolios and Specifications
Table 103. Amway Corporation OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Amway Corporation Main Business
Table 105. Amway Corporation Latest Developments
Table 106. Bayer Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 107. Bayer OTC Medicine Product Portfolios and Specifications
Table 108. Bayer OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Bayer Main Business
Table 110. Bayer Latest Developments
Table 111. Aktienge Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 112. Aktienge OTC Medicine Product Portfolios and Specifications
Table 113. Aktienge OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Aktienge Main Business
Table 115. Aktienge Latest Developments
Table 116. Sanofi Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi OTC Medicine Product Portfolios and Specifications
Table 118. Sanofi OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. Pfizer Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer OTC Medicine Product Portfolios and Specifications
Table 123. Pfizer OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Pfizer Main Business
Table 125. Pfizer Latest Developments
Table 126. Reckitt Benckiser Group Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 127. Reckitt Benckiser Group OTC Medicine Product Portfolios and Specifications
Table 128. Reckitt Benckiser Group OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Reckitt Benckiser Group Main Business
Table 130. Reckitt Benckiser Group Latest Developments
Table 131. Church & Dwight Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 132. Church & Dwight OTC Medicine Product Portfolios and Specifications
Table 133. Church & Dwight OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. Church & Dwight Main Business
Table 135. Church & Dwight Latest Developments
Table 136. Bayer HealthCare Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 137. Bayer HealthCare OTC Medicine Product Portfolios and Specifications
Table 138. Bayer HealthCare OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Bayer HealthCare Main Business
Table 140. Bayer HealthCare Latest Developments
Table 141. AstraZeneca Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 142. AstraZeneca OTC Medicine Product Portfolios and Specifications
Table 143. AstraZeneca OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. AstraZeneca Main Business
Table 145. AstraZeneca Latest Developments
Table 146. BioGaia Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 147. BioGaia OTC Medicine Product Portfolios and Specifications
Table 148. BioGaia OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. BioGaia Main Business
Table 150. BioGaia Latest Developments
Table 151. Bristol Myers Squibb Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 152. Bristol Myers Squibb OTC Medicine Product Portfolios and Specifications
Table 153. Bristol Myers Squibb OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Bristol Myers Squibb Main Business
Table 155. Bristol Myers Squibb Latest Developments
Table 156. Chr. Hansen Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 157. Chr. Hansen OTC Medicine Product Portfolios and Specifications
Table 158. Chr. Hansen OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Chr. Hansen Main Business
Table 160. Chr. Hansen Latest Developments
Table 161. Cipla Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 162. Cipla OTC Medicine Product Portfolios and Specifications
Table 163. Cipla OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Cipla Main Business
Table 165. Cipla Latest Developments
Table 166. CoLucid Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 167. CoLucid OTC Medicine Product Portfolios and Specifications
Table 168. CoLucid OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. CoLucid Main Business
Table 170. CoLucid Latest Developments
Table 171. Daiichi Sankyo Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 172. Daiichi Sankyo OTC Medicine Product Portfolios and Specifications
Table 173. Daiichi Sankyo OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Daiichi Sankyo Main Business
Table 175. Daiichi Sankyo Latest Developments
Table 176. Friggs Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 177. Friggs OTC Medicine Product Portfolios and Specifications
Table 178. Friggs OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Friggs Main Business
Table 180. Friggs Latest Developments
Table 181. DSM Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 182. DSM OTC Medicine Product Portfolios and Specifications
Table 183. DSM OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. DSM Main Business
Table 185. DSM Latest Developments
Table 186. Eisai Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 187. Eisai OTC Medicine Product Portfolios and Specifications
Table 188. Eisai OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Eisai Main Business
Table 190. Eisai Latest Developments
Table 191. Eli Lilly Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 192. Eli Lilly OTC Medicine Product Portfolios and Specifications
Table 193. Eli Lilly OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. Eli Lilly Main Business
Table 195. Eli Lilly Latest Developments
Table 196. Herbalife Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 197. Herbalife OTC Medicine Product Portfolios and Specifications
Table 198. Herbalife OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Herbalife Main Business
Table 200. Herbalife Latest Developments
Table 201. Euradite Basic Information, OTC Medicine Manufacturing Base, Sales Area and Its Competitors
Table 202. Euradite OTC Medicine Product Portfolios and Specifications
Table 203. Euradite OTC Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Euradite Main Business
Table 205. Euradite Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of OTC Medicine
Figure 2. OTC Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Medicine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global OTC Medicine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. OTC Medicine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Gastrointestinal Tract
Figure 10. Product Picture of Dermatology
Figure 11. Product Picture of Otolaryngology
Figure 12. Product Picture of Nutrition/Vitamins
Figure 13. Product Picture of Others
Figure 14. Global OTC Medicine Sales Market Share by Type in 2023
Figure 15. Global OTC Medicine Revenue Market Share by Type (2019-2024)
Figure 16. OTC Medicine Consumed in Pharmacy
Figure 17. Global OTC Medicine Market: Pharmacy (2019-2024) & (K Units)
Figure 18. OTC Medicine Consumed in Hospital Pharmacy
Figure 19. Global OTC Medicine Market: Hospital Pharmacy (2019-2024) & (K Units)
Figure 20. OTC Medicine Consumed in Online Retailer
Figure 21. Global OTC Medicine Market: Online Retailer (2019-2024) & (K Units)
Figure 22. OTC Medicine Consumed in Others
Figure 23. Global OTC Medicine Market: Others (2019-2024) & (K Units)
Figure 24. Global OTC Medicine Sales Market Share by Application (2023)
Figure 25. Global OTC Medicine Revenue Market Share by Application in 2023
Figure 26. OTC Medicine Sales Market by Company in 2023 (K Units)
Figure 27. Global OTC Medicine Sales Market Share by Company in 2023
Figure 28. OTC Medicine Revenue Market by Company in 2023 ($ Million)
Figure 29. Global OTC Medicine Revenue Market Share by Company in 2023
Figure 30. Global OTC Medicine Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global OTC Medicine Revenue Market Share by Geographic Region in 2023
Figure 32. Americas OTC Medicine Sales 2019-2024 (K Units)
Figure 33. Americas OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 34. APAC OTC Medicine Sales 2019-2024 (K Units)
Figure 35. APAC OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 36. Europe OTC Medicine Sales 2019-2024 (K Units)
Figure 37. Europe OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa OTC Medicine Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 40. Americas OTC Medicine Sales Market Share by Country in 2023
Figure 41. Americas OTC Medicine Revenue Market Share by Country in 2023
Figure 42. Americas OTC Medicine Sales Market Share by Type (2019-2024)
Figure 43. Americas OTC Medicine Sales Market Share by Application (2019-2024)
Figure 44. United States OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC OTC Medicine Sales Market Share by Region in 2023
Figure 49. APAC OTC Medicine Revenue Market Share by Regions in 2023
Figure 50. APAC OTC Medicine Sales Market Share by Type (2019-2024)
Figure 51. APAC OTC Medicine Sales Market Share by Application (2019-2024)
Figure 52. China OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 56. India OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe OTC Medicine Sales Market Share by Country in 2023
Figure 60. Europe OTC Medicine Revenue Market Share by Country in 2023
Figure 61. Europe OTC Medicine Sales Market Share by Type (2019-2024)
Figure 62. Europe OTC Medicine Sales Market Share by Application (2019-2024)
Figure 63. Germany OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 64. France OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa OTC Medicine Sales Market Share by Country in 2023
Figure 69. Middle East & Africa OTC Medicine Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa OTC Medicine Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa OTC Medicine Sales Market Share by Application (2019-2024)
Figure 72. Egypt OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of OTC Medicine in 2023
Figure 78. Manufacturing Process Analysis of OTC Medicine
Figure 79. Industry Chain Structure of OTC Medicine
Figure 80. Channels of Distribution
Figure 81. Global OTC Medicine Sales Market Forecast by Region (2025-2030)
Figure 82. Global OTC Medicine Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global OTC Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global OTC Medicine Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global OTC Medicine Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global OTC Medicine Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of OTC Medicine
Figure 2. OTC Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Medicine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global OTC Medicine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. OTC Medicine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Gastrointestinal Tract
Figure 10. Product Picture of Dermatology
Figure 11. Product Picture of Otolaryngology
Figure 12. Product Picture of Nutrition/Vitamins
Figure 13. Product Picture of Others
Figure 14. Global OTC Medicine Sales Market Share by Type in 2023
Figure 15. Global OTC Medicine Revenue Market Share by Type (2019-2024)
Figure 16. OTC Medicine Consumed in Pharmacy
Figure 17. Global OTC Medicine Market: Pharmacy (2019-2024) & (K Units)
Figure 18. OTC Medicine Consumed in Hospital Pharmacy
Figure 19. Global OTC Medicine Market: Hospital Pharmacy (2019-2024) & (K Units)
Figure 20. OTC Medicine Consumed in Online Retailer
Figure 21. Global OTC Medicine Market: Online Retailer (2019-2024) & (K Units)
Figure 22. OTC Medicine Consumed in Others
Figure 23. Global OTC Medicine Market: Others (2019-2024) & (K Units)
Figure 24. Global OTC Medicine Sales Market Share by Application (2023)
Figure 25. Global OTC Medicine Revenue Market Share by Application in 2023
Figure 26. OTC Medicine Sales Market by Company in 2023 (K Units)
Figure 27. Global OTC Medicine Sales Market Share by Company in 2023
Figure 28. OTC Medicine Revenue Market by Company in 2023 ($ Million)
Figure 29. Global OTC Medicine Revenue Market Share by Company in 2023
Figure 30. Global OTC Medicine Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global OTC Medicine Revenue Market Share by Geographic Region in 2023
Figure 32. Americas OTC Medicine Sales 2019-2024 (K Units)
Figure 33. Americas OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 34. APAC OTC Medicine Sales 2019-2024 (K Units)
Figure 35. APAC OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 36. Europe OTC Medicine Sales 2019-2024 (K Units)
Figure 37. Europe OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa OTC Medicine Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa OTC Medicine Revenue 2019-2024 ($ Millions)
Figure 40. Americas OTC Medicine Sales Market Share by Country in 2023
Figure 41. Americas OTC Medicine Revenue Market Share by Country in 2023
Figure 42. Americas OTC Medicine Sales Market Share by Type (2019-2024)
Figure 43. Americas OTC Medicine Sales Market Share by Application (2019-2024)
Figure 44. United States OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC OTC Medicine Sales Market Share by Region in 2023
Figure 49. APAC OTC Medicine Revenue Market Share by Regions in 2023
Figure 50. APAC OTC Medicine Sales Market Share by Type (2019-2024)
Figure 51. APAC OTC Medicine Sales Market Share by Application (2019-2024)
Figure 52. China OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 56. India OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe OTC Medicine Sales Market Share by Country in 2023
Figure 60. Europe OTC Medicine Revenue Market Share by Country in 2023
Figure 61. Europe OTC Medicine Sales Market Share by Type (2019-2024)
Figure 62. Europe OTC Medicine Sales Market Share by Application (2019-2024)
Figure 63. Germany OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 64. France OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa OTC Medicine Sales Market Share by Country in 2023
Figure 69. Middle East & Africa OTC Medicine Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa OTC Medicine Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa OTC Medicine Sales Market Share by Application (2019-2024)
Figure 72. Egypt OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country OTC Medicine Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of OTC Medicine in 2023
Figure 78. Manufacturing Process Analysis of OTC Medicine
Figure 79. Industry Chain Structure of OTC Medicine
Figure 80. Channels of Distribution
Figure 81. Global OTC Medicine Sales Market Forecast by Region (2025-2030)
Figure 82. Global OTC Medicine Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global OTC Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global OTC Medicine Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global OTC Medicine Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global OTC Medicine Revenue Market Share Forecast by Application (2025-2030)
